Journal
JOURNAL OF MATERIALS CHEMISTRY B
Volume 6, Issue 28, Pages 4687-4696Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c8tb00733k
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [51573111]
- Program for Changjiang Scholars and Innovative Research Team in University [IRT-15R48]
- Fundamental Research Funds for the Central Universities
Ask authors/readers for more resources
Multimodal and synergistic therapy of cancer has appeared as one of the most promising strategies in treating cancer. Here, we report a supramolecular hierarchical nanocomposite for combination photodynamic, photothermal, and chemotherapy. Graphene oxide (GO, photothermal agent for photothermal therapy, PTT), protoporphyrin IX (PpIX, photosensitizer for photodynamic therapy, PDT), and hydrophilic anticancer drug doxorubicin hydrochloride (DOXHCl , therapeutic for chemotherapy) are involved in hierarchical self-assembled nanocomposites via supramolecular interactions. PEGylated PpIX (PEG-PpIX) is prepared to improve the stability of GO in physiological conditions. The nanocomposite GO(PEG-PpIX) is non-cytotoxic in the dark and phototoxic with light irradiation to exhibit efficient PTT and PDT effects. The drug loading content of the nanocomposite DOX/GO(PEG-PpIX) is as high as 15.9% and the drug release shows a pH-dependent profile. The combined PDT, PTT, and chemotherapy shows an excellent in vivo antitumor effect and side effect reduction. This work presents a facile yet robust strategy to fabricate a nanocomposite for multimodal synergistic therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available